Conclusions: L11 and LR can effectively reduce obesity by modulating gut microbiota and activating the PPAR–AMPK pathway, leading to decreased liver injury and systemic inflammation in mice fed with an HFD. The gene discussed is PPARA; the disease is obesity disorder.